Bill Ackman Pershing Square Capital Management
Bill Ackman is the founder and CEO of Pershing Square Capital Management, a New York–based hedge fund. He employs an activist investing approach, seeking to influence the management and direction of the publicly traded companies in which he invests. Frequently in the public eye, Ackman has been noted for both high-profile successes and controversies, such as his well-known short position in Herbalife.
Top Buys
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$324M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.62% |
| 2 | Materials | 25.86% |
| 3 | Consumer Staples | 15.61% |
| 4 | Industrials | 14.28% |
| 5 | Consumer Discretionary | 11.4% |
Similar funds
Bill Ackman's Q4 2015 Portfolio in Review
As of Q4 2015, Bill Ackman held 8 positions worth $12.5B, down 11% from $14B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q4 2015: portfolio turnover was 0%. Bill Ackman opened no new positions and made no exits, leaving the 8-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 37% a quarter earlier, followed by Materials and Consumer Staples.
- Bill Ackman's biggest Q4 2015 reduction was Bausch Health, cutting an estimated $324M.
- Bill Ackman's ten largest holdings make up 100% of its $12.5B portfolio in Q4 2015.
- Bill Ackman opened 0 new positions and closed 0 in Q4 2015.
- Bill Ackman's portfolio value fell 11% quarter-over-quarter to $12.5B.
Based on Pershing Square Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.